You are here: Industry Insights > Series B financing

News List

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China prnasia
January 11, 2021
VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for patients in Greater China, announced today the closing of a $150 million Series B financing.
Neurogene closes $115m series B financing pharmaceutical-business-review
December 21, 2020
Neurogene, a company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced the completion of a $115m Series B financing.
Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products prnasia
December 16, 2020
Singlera Genomics Inc. announced that it raised $150 million in Series B financing. This round of financing was led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Capital and Furong Investment.
Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million prnasia
November 09, 2020
Inmagene Biopharmaceuticals, announced today that it had closed a $21 million Series B financing, led by Vertex Ventures China, and co-invested by Panacea Venture, Kunlun Capital, SCVC and a few other investors.
Cullinan Oncology completes $98.5m Series B financing pharmaceutical-business-review
June 09, 2020
Cullinan Oncology, LLC announced today the closing of a $98.5 million Series B financing, which will be used to support ongoing clinical trials across its small molecule and biologics portfolio.
Silverback Therapeutics raises $78.5m in oversubscribed Series B financing pharmaceutical-business-review
March 13, 2020
Silverback Therapeutics, a private biopharmaceutical company pioneering a new class of immune-modulating ImmunoTAC drug conjugates targeting previously inaccessible disease pathways ...
Akouos closes $105m Series B financing pharmaceutical-business-review
March 05, 2020
Akouos, Inc., a precision genetic medicine company developing potential gene therapies to restore, improve or preserve hearing, announced it has raised $105 million in an oversubscribed Series B financing.
Cellestia Biotech AG Successfully Closes Series B Financing Round, Raising a Total of CHF 20 Million b3cnewswire
December 18, 2019
Cellestia Biotech AG announced the closing of a CHF 20 million Series B financing round. The new funds will be added to the previous, including CHF 8 million Seed financing ...
Cellestia Biotech AG successfully closes Series B financing round, raising a total of CHF 20 million firstwordpharma
December 17, 2019
Guido Guidi elected new Chairman of the Board of Directors and Robert Karsunky elected new Chairman of the Audit Committee and Board of Directors Member
Japanese AI startup secures $42.9M in series B financing biospectrumasia
October 08, 2019
The company intends to use the latest funding for the promotion of clinical trials, to further the development pipeline, acquisition of expert personnel, investment in equipment and overseas expansion.

Previous page 1 2 3 Next page